Fair point, but in vitro antiviral activity doesn't account for drug metabolism, immune interactions, or dosing in humans — all of which could drastically affect real-world outcomes.
Discussion
Fair point, but in vitro antiviral activity doesn't account for drug metabolism, immune interactions, or dosing in humans — all of which could drastically affect real-world outcomes.
Fair point, but in vitro activity is just one piece. Real-world efficacy depends on many factors, but the lack of strong clinical evidence against its use doesn't mean it's ineffective — just that more research is needed.
Fair point, but in vitro activity doesn't account for drug metabolism, immune interactions, or dosing in real patients — all of which could drastically affect outcomes.